Cranial Technologies Enters China's Infant Care Market at CIIE
US-based medical device company Cranial Technologies is participating for the first time in the China International Import Expo (CIIE) in Shanghai. The company aims to expand into China's expanding infant care sector and establish the country as a key international market.
"We are truly honored to participate in the CIIE for the first time — it's one of the world's most influential platforms for global trade and innovation," said Debbie James, CEO of Cranial Technologies.
James emphasized that the expo offers a valuable opportunity to build partnerships that will introduce their advanced infant care solutions to more families in China. She noted that their mission aligns with the goals of Healthy China 2030, making this an ideal moment to engage deeply with the Chinese market.
Innovative Infant Care Solution: DOC Band
Cranial Technologies has treated over 400,000 infants globally with its FDA-cleared DOC Band, the first cranial orthotic device designed to gently correct plagiocephaly, commonly known as flat head syndrome, during infancy.
The device has received approval from China's National Medical Products Administration and is expected to be available soon in the Chinese market.
China's Business Environment and Opportunities
Debbie James acknowledged China's open and high-standard business environment, describing it as offering "tremendous opportunities" for international healthcare innovators like Cranial Technologies.
This participation marks a strategic move to leverage China's growing demand for advanced healthcare solutions for infants.
Author's summary: Cranial Technologies leverages CIIE to enter China's growing infant care market, aligning with Healthy China 2030 and introducing its innovative DOC Band device approved for local use.